다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
International journal of chronic obstructive pulmonary disease : IJCOPD, v.8, 2013년, pp.561 - 568
Kim, JinHee (Office of Health Service Research, National Evidence-Based Healthcare Collaborating Agency, Seoul, Korea) , Rhee, Chin Kook (Department of Internal Medicine, Seoul St Mary’s Hospital, Catholic University of Korea College of Medicine, Seoul, Korea) , Yoo, Kwang Ha (Department of Internal Medicine, Konkuk University School of Medicine, Seoul, Korea) , Kim, Young Sam (Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea) , Lee, Sei Won (Department of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea) , Park, Yong Bum (Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Internal Medicine, Hallym University Kangdong Sacred Heart Hospital, Seoul, Korea) , Lee, Jin Hwa (Department of Internal Medicine, School of Medicine, Ewha Womans University, Seoul, Korea) , Oh, YeonMok (Department of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea) , Lee, Sang Do (Department of Pulmonary and Critical Care Medicine, Asan Medical Center, University of) , Kim, Yuri , Kim, KyungJoo , Yoon, HyoungKyu
AI-Helper
BackgroundPatients with high grade chronic pulmonary obstructive disease (COPD) account for much of the COPD-related mortality and incur excessive financial burdens and medical care utilization. We aimed to determine the characteristics and medical care use of such patients using nationwide data fro...
1 Halpin DM Miravitlles M Chronic obstructive pulmonary disease: the disease and its burden to society Proc Am Thorac Soc 2006 3 7 619 623 16963544
2 Jensen HH Godtfredsen NS Lange P Vestbo J Potential misclassification of causes of death from COPD Eur Respir J 2006 28 4 781 785 16807258
3 Jensen MB Fenger-Grøn M Fonager K Omland Ø Vinding AL Hansen JG Chronic obstructive pulmonary disease involves substantial health-care service and social benefit costs Dan Med J 2013 60 1 A4557 23340185
4 Miravitlles M Murio C Guerrero T Gisbert R Costs of chronic bronchitis and COPD: a 1-year follow-up study Chest 2003 123 3 784 791 12628879
5 Detournay B Pribil C Fournier M SCOPE Group The SCOPE study: health-care consumption related to patients with chronic obstructive pulmonary disease in France Value Health 2004 7 2 168 174 15164806
6 Jones PW Health status and the spiral of decline COPD 2009 6 1 59 63 19229709
7 Hurst JR Vestbo J Anzueto A Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Investigators Susceptibility to exacerbation in chronic obstructive pulmonary disease N Engl J Med 2010 363 12 1128 1138 20843247
8 Global Initiative for Chronic Obstructive Lung Disease [homepage on the Internet] Global strategy for the diagnosis, management and prevention of COPD 2011 [updated Feb 2013]. Available from: http://www.goldcopd.org/Guidelines/guidelines-resources.html
9 Lee SY Jung KY Lee IK Korean Epilepsy Society Prevalence of treated epilepsy in Korea based on national health insurance data J Korean Med Sci 2012 27 3 285 290 22379340
10 Korean National Health Insurance Cooperation Seoul Annual Report of National Health Insurance Statistics, 2008 Seoul Division of statistical analysis, Korean National Health Insurance Cooperation 2008 Available from: http://www.nhis.or.kr/portal/site/main/MENU_WBDDG02/ Accessed August 2013
11 Prescott E Lange P Vestbo J Socioeconomic status, lung function and admission to hospital for COPD: results from the Copenhagen City Heart Study Eur Respir J 1999 13 5 1109 1114 10414412
12 Sin DD Anthonisen NR Soriano JB Agusti AG Mortality in COPD: role of comorbidities Eur Respir J 2006 28 6 1245 1257 17138679
13 Mannino DM Thorn D Swensen A Holguin F Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD Eur Respir J 2008 32 4 962 969 18579551
14 Gan WQ Man SF Sin DD The interactions between cigarette smoking and reduced lung function on systemic inflammation Chest 2005 127 2 558 564 15705996
15 Burgel PR Paillasseur JL Caillaud D Initiatives BPCO Scientific Committee Clinical COPD phenotypes: a novel approach using principal component and cluster analyses Eur Respir J 2010 36 3 531 539 20075045
16 de Miguel Diez J Carrasco Garrido P García Carballo M Determinants and predictors of the cost of COPD in primary care: a Spanish perspective Int J Chron Obstruct Pulmon Dis 2008 3 4 701 712 19281084
17 Jansson SA Andersson F Borg S Ericsson A Jönsson E Lundbäck B Costs of COPD in Sweden according to disease severity Chest 2002 122 6 1994 2002 12475838
18 Faganello MM Tanni SE Sanchez FF Pelegrino NR Lucheta PA Godoy I BODE index and GOLD staging as predictors of 1-year exacerbation risk in chronic obstructive pulmonary disease Am J Med Sci 2010 339 1 10 14 19926966
19 Masa JF Sobradillo V Villasante C Costes de la EPOC en España. Estimación a partir de un estudio epidemiológico poblacional. [Costs of chronic obstructive pulmonary disease in Spain. Estimation from a population-based study.] Arch Bronconeumol 2004 40 2 72 79 Spanish 14746730
20 Hoogendoorn M Feenstra TL Hoogenveen RT Al M Mölken MR Association between lung function and exacerbation frequency in patients with COPD Int J Chron Obstruct Pulmon Dis 2010 5 435 444 21191438
21 Menn P Heinrich J Huber RM KORA Study Group Direct medical costs of COPD – an excess cost approach based on two population-based studies Respir Med 2012 106 4 540 548 22100535
22 Burge PS Calverley PM Jones PW Spencer S Anderson JA Maslen TK Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial BMJ 2000 320 7245 1297 1303 10807619
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
오픈액세스 학술지에 출판된 논문
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.